Intervertebral Disk Nucleolysis is a medical procedure used to treat intervertebral disc herniation, a condition where the soft cushioning discs between the vertebrae in the spine become damaged or displaced.
During this procedure, a specially trained healthcare professional, typically an interventional radiologist or a spinal surgeon, uses a needle to inject a solution of enzymes or a chemical agent directly into the affected disc. These enzymes or chemicals work to break down and dissolve the gel-like substance in the disc, known as the nucleus pulposus, that is causing pressure and pain on the surrounding nerves.
The purpose of Intervertebral Disk Nucleolysis is to reduce the size of the protruding or herniated disc and relieve the associated symptoms, such as back pain, leg pain, tingling, or numbness. By dissolving a portion of the disc material, it aims to alleviate pressure on the affected nerves and restore normal functionality and range of motion to the spine.
This procedure is performed under local anesthesia, typically on an outpatient basis, meaning that the patient can return home shortly after the procedure. It is considered a minimally invasive alternative to more invasive surgical options, such as discectomy or spinal fusion, and may be recommended when conservative treatments, such as medication, physical therapy, or rest, have failed to provide sufficient relief. However, it should be noted that Intervertebral Disk Nucleolysis is not suitable for all cases of intervertebral disc herniation, and the suitability of the procedure depends on various factors, including the location and severity of the herniation, the overall health of the patient, and their individual medical history. A thorough evaluation and consultation with a healthcare professional are necessary to determine the appropriateness of this treatment option.
